NVET

Nexvet Biopharma plc Ordinary Shares
NVET

Delisted

NVET was delisted on the 28th of July, 2017.

17 hedge funds and large institutions have $50.7M invested in Nexvet Biopharma plc Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
17
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FCM
1
Farallon Capital Management
California
$20.1M +$20.1M +2,499,996 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$10.6M +$10.6M +1,322,870 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$7.03M +$7.03M +875,000 New
FCMI
4
Foresite Capital Management II
California
$5.69M +$5.69M +708,332 New
Jennison Associates
5
Jennison Associates
New York
$3.72M +$3.72M +463,506 New
ACPU
6
Arrowgrass Capital Partners (US)
Delaware
$2.15M +$2.15M +267,500 New
Norges Bank
7
Norges Bank
Norway
$361K +$361K +45,000 New
CC
8
CQS Cayman
Cayman Islands
$281K +$281K +35,000 New
Bank of America
9
Bank of America
North Carolina
$237K +$237K +29,524 New
Goldman Sachs
10
Goldman Sachs
New York
$156K +$156K +19,379 New
Millennium Management
11
Millennium Management
New York
$153K +$153K +19,000 New
SIM
12
Spark Investment Management
New York
$123K +$123K +16,900 New
Deutsche Bank
13
Deutsche Bank
Germany
$82K +$82K +10,220 New
Morgan Stanley
14
Morgan Stanley
New York
$37K +$37K +4,677 New
Citigroup
15
Citigroup
New York
$13K +$13K +1,600 New
UBS Group
16
UBS Group
Switzerland
$5K +$5K +667 New
TRCT
17
Tower Research Capital (TRC)
New York
$1K +$1K +155 New